Exclusive

Publication

Byline

Location

Clinical Trial: Developing New Ways to Detect Respiratory Impairment Early in ALS

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844590) titled 'Developing New Ways to Detect Respiratory Impairment Early in ALS' on Sept. 21. Brief Sum... Read More


Clinical Trial: Nutritional Responses to Acute Exercise Performed on the LipoxMax in Obese Adolescents

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844330) titled 'Nutritional Responses to Acute Exercise Performed on the LipoxMax in Obese Adolescents' on... Read More


Clinical Trial: A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843498) titled 'A Phase III Study to Evaluate the Efficacy and Safety of Petrelintide in Participants With... Read More


Clinical Trial: Gastrointestinal Symptoms in Children With Type 1 Diabetes

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07845175) titled 'Gastrointestinal Symptoms in Children With Type 1 Diabetes' on Sept. 22. Brief Summary: T... Read More


Clinical Trial: Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-resistant Depression.

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843927) titled 'Dehydroepiandrosterone (DHEA) as Augmentation of Standard Antidepressants in Treatment-res... Read More


Clinical Trial: Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol Use in Outpatients With Alcohol Use Disorder

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07844720) titled 'Study on Thiamine Supplementation to REduce braiN Injury Associated With Chronic Alcohol U... Read More


Clinical Trial: Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus

U.S., Sept. 29 -- ClinicalTrials.gov registry received information related to the study (NCT07843420) titled 'Nemolizumab for the Treatment of Moderate to Severe Chronic Hepatic Pruritus' on Sept. 21.... Read More


U.S. CUSTOMS AND BORDER PROTECTION ISSUES NOTICE: ACCREDITATION AND APPROVAL OF LABORATORY SERVICES, INC. (KEMAH, TX) AS A COMMERCIAL GAUGER AND LABORATORY

WASHINGTON, Sept. 29 -- U.S. Customs and Border Protection has issued a notice called: Accreditation and Approval of Laboratory Services, Inc. (Kemah, TX) as a Commercial Gauger and Laboratory. The n... Read More


U.S. CUSTOMS AND BORDER PROTECTION ISSUES NOTICE: ACCREDITATION AND APPROVAL OF INTERTEK USA, INC. (CHELSEA, MA), AS A COMMERCIAL GAUGER AND LABORATORY

WASHINGTON, Sept. 29 -- U.S. Customs and Border Protection has issued a notice called: Accreditation and Approval of Intertek USA, Inc. (Chelsea, MA), as a Commercial Gauger and Laboratory. The notic... Read More


COAST GUARD ISSUES NOTICE: GUIDANCE ON THE STREAMLINED INSPECTION PROGRAM; REOPENING OF COMMENT PERIOD

WASHINGTON, Sept. 29 -- Coast Guard has issued a notice called: Guidance on the Streamlined Inspection Program; Reopening of Comment Period. The notice was published in the Federal Register on Sept. ... Read More